- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2011-005491-41. Displaying page 1 of 1.
|EudraCT Number: 2011-005491-41||Sponsor Protocol Number: B1931022||Start Date*: 2012-06-13|
|Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017|
|Full Title: An Open-label, Randomized Phase 3 Study of Inotuzumab Ozogamicin Compared to a Defined Investigator’s Choice in Adult Patients with Relapsed or Refractory CD22-Positive Acute Lymphoblastic Leukemia...|
|Medical condition: Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia|
|Population Age: Adults, Elderly||Gender: Male, Female|
|Trial protocol: HU (Completed) CZ (Completed) SK (Completed) SE (Completed) ES (Completed) GB (Ongoing) DE (Completed) FI (Completed) IT (Ongoing) NL (Completed) BE (Completed)|
|Trial results: View results|
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
|Number of Trials to download:|
• Outside EU/EEA: Date study was submitted in EudraCT
Query did not match any studies.